We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has cited a California hospital’s institutional review board (IRB) for inadequately reviewing clinical device trials and failing to provide accurate documentation about its membership and oversight process.